Prostate Cancer - Results from #21620

Metastatic castration-resistant prostate cancer: New therapies, novel combination strategies and implications for immunotherapy - Abstract December 24, 2013

Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist - Abstract December 24, 2013

Coffee consumption and risk of nonaggressive, aggressive and fatal prostate cancer--a dose-response meta-analysis - Abstract December 24, 2013

Preoperative endorectal MRI in prostate cancer: A monocentric retrospective cohort - Abstract December 24, 2013

Dose-escalated salvage radiotherapy after radical prostatectomy in high risk prostate cancer patients without hormone therapy: Outcome, prognostic factors and late toxicity - Abstract December 24, 2013

Prediction of extraprostatic extension in patients with clinically organ-confined prostate cancer - Abstract December 24, 2013

Evolution of the treatment paradigm for patients with metastatic castration-resistant prostate cancer - Abstract December 23, 2013

The Cancer of the Prostate Risk Assessment (CAPRA) score predicts biochemical recurrence in intermediate risk prostate cancer treated with external beam radiotherapy (EBRT) dose escalation or low-dose rate (LDR) brachytherapy - Abstract December 23, 2013

Online prostate cancer screening decision aid for at-risk men: A randomized trial - Abstract December 23, 2013

Screening of prostate cancer seen by general practitioners - Abstract December 23, 2013

Statin use and risk of prostate cancer: A Danish population-based case-control study, 1997-2010 - Abstract December 23, 2013

PCA3 score of 20 could improve prostate cancer detection: Results obtained on 734 Italian individuals - Abstract December 21, 2013

Prostate cancer: Diffusion-weighted imaging versus dynamic-contrast enhanced imaging for tumor localization-a meta-analysis - Abstract December 21, 2013

Single session of high-intensity focused ultrasound for localized prostate cancer: Treatment outcomes and potential effect as a primary therapy - Abstract December 21, 2013

Comparison of prostate cancer volume measured by HistoScanning™ and final histopathological results - Abstract December 20, 2013

Use of apparent diffusion coefficient as a response biomarker in bone: Effect of developing sclerosis on quantified values - Abstract December 20, 2013

Intratumoral hypoxia as the genesis of genetic instability and clinical prognosis in prostate cancer - Abstract December 20, 2013

No improvement noted in overall or cause-specific survival for men presenting with metastatic prostate cancer over a 20-year period - Abstract December 20, 2013

Abiraterone acetate: A review of its use in patients with metastatic castration-resistant prostate cancer - Abstract December 20, 2013

Combination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer - Abstract December 20, 2013

Page 1082 of 1438